GOLDMAN SACHS GROUP INC - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 66 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$31,412,749
+21.1%
4,332,793
+26.8%
0.01%0.0%
Q1 2024$25,939,569
+4158.7%
3,417,598
+2453.0%
0.01%
Q4 2023$609,095
+13.7%
133,867
-1.3%
0.00%
Q3 2023$535,624
+26.7%
135,601
+0.4%
0.00%
Q2 2023$422,854
-47.2%
135,097
-23.6%
0.00%
Q1 2023$801,271
+72.2%
176,881
+57.0%
0.00%
Q4 2022$465,393
+238563.1%
112,686
+84.9%
0.00%
Q3 2022$195
-99.9%
60,930
+366.8%
0.00%
Q3 2021$151,000
+7.1%
13,053
-8.8%
0.00%
Q2 2021$141,00014,3140.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Owl Capital Holdings LP 3,859,468$27,981,1437.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 21,231,974$153,931,8122.56%
Altium Capital Management LP 693,000$5,024,2502.05%
STEMPOINT CAPITAL LP 704,349$5,106,5301.50%
DAFNA Capital Management LLC 639,974$4,639,8121.11%
RA Capital Management 6,045,351$43,828,7950.58%
Altium Capital Management LP 196,000$1,421,0000.58%
MANGROVE PARTNERS IM, LLC 855,815$6,204,6590.48%
Ikarian Capital, LLC 323,528$2,345,5780.41%
SPHERA FUNDS MANAGEMENT LTD. 312,469$2,265,4000.31%
View complete list of LARIMAR THERAPEUTICS INC shareholders